Comparison of QRISK and Anderson Framingham risk equation in classification of female patients’ 10 year risk of cardiovascular disease (low (<10%), intermediate (10% to <20%), high (≥20%)) and observed and predicted risk
Anderson Framingham | QRISK | Total No (%) of patients reclassified | ||
---|---|---|---|---|
Low risk | Intermediate risk | High risk | ||
Low risk | ||||
No of patients | 384 923 | 10 901 | 687 | 11 588 (2.1) |
No of cardiovascular events | 5 589 | 1 140 | 106 | |
% of patients classified | 70.9 | 2.0 | 0.3 | |
Average predicted risk of cardiovascular event (%): | ||||
QRISK | 2.7 | 12.7 | 23.2 | |
Anderson Framingham | 3.8 | 8.4 | 8.4 | |
Observed risk % (95% CI) | 3.1 (3.0 to 3.2) | 18.6 (17.3 to 20.0) | 29.0 (22.7 to 36.7) | |
Intermediate risk | ||||
No of patients | 48 729 | 61 925 | 10 010 | 58 739 (10.8) |
No of cardiovascular events | 1 943 | 4 814 | 1 340 | |
% of patients classified | 9.0 | 11.4 | 1.8 | |
Average predicted risk of cardiovascular event (%): | ||||
QRISK | 7.5 | 14.0 | 23.9 | |
Anderson Framingham | 12.5 | 14.4 | 15.6 | |
Observed risk % (95% CI) | 7.5 (7.0 to 7.9) | 14.1 (13.6 to 14.6) | 22.7 (21.2 to 24.3) | |
High risk | ||||
No of patients | 940 | 12 626 | 12 246 | 13 566 (2.5) |
No of cardiovascular events | 73 | 1 251 | 1 771 | |
% of patients classified | 0.2 | 2.3 | 2.3 | |
Average predicted risk of cardiovascular event (%): | ||||
QRISK | 8.5 | 15.8 | 25.9 | |
Anderson Framingham | 22.8 | 24.0 | 28.0 | |
Observed risk % (95% CI) | 15.4 (10.9 to 21.3) | 16.9 (15.8 to 18.1) | 24.2 (22.9 to 25.6) |